Clinical Trial Update: Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial of a radiolabeled monoclonal antibody therapy for recurrent or persistent metastatic colorectal cancer has completed enrollment. The study aims …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Colon
• Adenocarcinoma of the Rectum
• Colon Cancer
• Rectal Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum | Phase 1 | Status: COMPLETED